In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Amicus Therapeutics Inc (NASDAQ: FOLD) closed at $10.14 in the last session, down -2.69% from day before closing price of $10.42. In other words, the price has decreased by -$2.69 from its previous closing price. On the day, 2.24 million shares were traded. FOLD stock price reached its highest trading level at $10.375 during the session, while it also had its lowest trading level at $10.11.
Ratios:
We take a closer look at FOLD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 2.78 whereas as Long-Term Debt/Eq ratio is at 2.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on December 19, 2023, Upgraded its rating to Overweight and sets its target price to $20 from $15 previously.
On September 09, 2022, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $14.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 01 ’24 when Campbell Bradley L sold 7,500 shares for $10.07 per share. The transaction valued at 75,524 led to the insider holds 886,654 shares of the business.
Campbell Bradley L sold 7,500 shares of FOLD for $87,496 on Apr 01 ’24. The President and CEO now owns 886,654 shares after completing the transaction at $11.67 per share. On Mar 05 ’24, another insider, MCGLYNN MARGARET G, who serves as the Director of the company, sold 7,500 shares for $13.40 each. As a result, the insider received 100,500 and left with 59,289 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 3003224832 and an Enterprise Value of 3236745728. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.52 while its Price-to-Book (P/B) ratio in mrq is 18.59. Its current Enterprise Value per Revenue stands at 8.105 whereas that against EBITDA is -49.325.
Stock Price History:
Over the past 52 weeks, FOLD has reached a high of $14.57, while it has fallen to a 52-week low of $9.70. The 50-Day Moving Average of the stock is -11.45%, while the 200-Day Moving Average is calculated to be -16.22%.
Shares Statistics:
According to the various share statistics, FOLD traded on average about 3.03M shares per day over the past 3-months and 2373710 shares per day over the past 10 days. A total of 293.59M shares are outstanding, with a floating share count of 287.34M. Insiders hold about 2.98% of the company’s shares, while institutions hold 106.50% stake in the company. Shares short for FOLD as of 1713139200 were 31317181 with a Short Ratio of 10.34, compared to 1710460800 on 32398992. Therefore, it implies a Short% of Shares Outstanding of 31317181 and a Short% of Float of 10.6400006.
